Micro Emerging Active

Jasper Therapeutics briquilimab progress and UBS coverage initiation

Score
0.4
Velocity
▲ 1.0
Articles
2
Sources
1

Summary

An article belongs to this narrative if it discusses Jasper Therapeutics' progress in briquilimab and UBS's coverage initiation of the company.

Sources

Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) … Yahoo Finance
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress … Yahoo Finance

Timeline

Last Updated Mar 29, 2026